WHO ICTRP trial
UTILIZZO DELLA BIVALIRUDINA PIU' IMPIANTO DI STENT IN LESIONI CORONARICHE LUNGHE…
EUCTR2012-001952-20-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2012-001952-20-IT |
|---|---|
| Public title | UTILIZZO DELLA BIVALIRUDINA PIU' IMPIANTO DI STENT IN LESIONI CORONARICHE LUNGHE NEL PREVENIRE LA MIONECROSI PERIPROCEDURALE |
| Scientific title | BIVALIRUDIN PLUS STENTING IN lONG LESION TO AVOID PERIPROCEDURAL MYOCARDIAL NECROSIS TRIAL. BILLION TRIAL - BILLION TRIAL |
| Primary sponsor | AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | patients with coronary artery disease after stent implantation in coronary long lesions (>25 mm) and undergoing non urgent percutaneous coronary intervention. MedDRA version: 14.1 Level: PT Classification code 10011089 Term: Coronary artery… |
| Interventions | Trade Name: ANGIOX*EV 10F 250MG Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: BIVALIRUDIN CAS Number: 128270-60-0 Concentration unit: mg milligram(s) Concentration type: up to Concentration number: 250- Trade… |
| Registration date | Dec 19, 2012 |
| Target size | 204 |
| Secondary IDs | NCT:01555658;BILLION TRIAL |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: